Reduction of early rejection in adult liver transplantation with ATG induction therapy

Transplant Proc. 1997 Feb-Mar;29(1-2):555-6. doi: 10.1016/s0041-1345(96)00264-3.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Adult
  • Antilymphocyte Serum / therapeutic use*
  • Azathioprine / therapeutic use
  • Communicable Diseases / epidemiology
  • Cyclosporine / therapeutic use
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Female
  • Graft Rejection / epidemiology
  • Graft Rejection / prevention & control*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Incidence
  • Liver Transplantation / immunology*
  • Male
  • Middle Aged
  • Muromonab-CD3 / therapeutic use
  • Postoperative Complications / epidemiology
  • Time Factors

Substances

  • Adrenal Cortex Hormones
  • Antilymphocyte Serum
  • Immunosuppressive Agents
  • Muromonab-CD3
  • Cyclosporine
  • Azathioprine